Elisa Coviello
Genoa, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Neutralizing monoclonal antibodies in haematological patients paucisymptomatic for COVID-19: The GIMEMA EMATO-0321 study.
Journal: British journal of haematology
Published: June 07, 2022
Lack of efficacy of convalescent plasma in COVID-19 patients with concomitant hematological malignancies: An Italian retrospective study.
Journal: Hematological oncology
Published: May 23, 2022
Secondary infections worsen the outcome of COVID-19 in patients with hematological malignancies: A report from the ITA-HEMA-COV.
Journal: Hematological oncology
Published: May 16, 2022
A prognostic model for patients with lymphoma and COVID-19: a multicentre cohort study.
Journal: Blood advances
Published: July 06, 2021
COVID-19 elicits an impaired antibody response against SARS-CoV-2 in patients with haematological malignancies.
Journal: British journal of haematology
Published: May 25, 2021
Dexamethasone, oxaliplatin and cytarabine (R-DHAOx) as salvage and stem cells mobilizing therapy in relapsed/refractory diffuse large B cell lymphomas.
Journal: Leukemia & lymphoma
Published: September 05, 2019
Prompt detection of L-asparaginase inactivation is crucial to optimize treatment efficacy also in aggressive lymphomas.
Journal: Hematological oncology
Published: September 17, 2017
Showing 1-9 of 9
Last Updated: 09/26/2026